Biomarin Pharmaceutical - Registered Shares PEG Ratio

The latest PEG ratio for BMRN is -206.32. That is below the Healthcare sector average of 1.26. Investors often review this figure alongside Biomarin Pharmaceutical - Registered Shares's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, BMRN currently prints -206.32 for PEG ratio, while the sector average sits near 1.26. That is roughly 16510.0% below the sector mean. Large gaps often invite a closer look at Biomarin Pharmaceutical - Registered Shares's growth, margins, and balance sheet.

A PEG ratio of -206.32 for Biomarin Pharmaceutical - Registered Shares is not 'good' or 'bad' on its own. Compare it with the peer average (1.26) and with BMRN's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting BMRN's PEG ratio (-206.32), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Biomarin Pharmaceutical - Registered Shares's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.